Valeant Returns to Bond Market to Refinance Debt Due in 2020

(Bloomberg) -- Valeant Pharmaceuticals International Inc. returned to the bond market to start refinancing the more than $4 billion of junk debt that the drugmaker has coming due starting in just o...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.